Stay updated on Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.

Latest updates to the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check24 days agoChange DetectedA notice was added at the top of the page about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference0.5%

- Check31 days agoChange DetectedThe site footer’s software revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page's revision history now shows a new entry: Revision: v3.7.0, and the previous entry Revision: v3.6.6 has been removed. This reflects an administrative update to the page's versioning rather than a substantive change to the study data or content.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision label, Revision: v3.6.6, was added to the history, replacing the previous version v3.6.5. This indicates a new version of the record was saved.SummaryDifference0.1%

Stay in the know with updates to Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.